Bergandi, L.; Canosa, S.; Carosso, A.R.; Paschero, C.; Gennarelli, G.; Silvagno, F.; Benedetto, C.; Revelli, A.
Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization. Pharmaceuticals 2020, 13, 136.
https://doi.org/10.3390/ph13070136
AMA Style
Bergandi L, Canosa S, Carosso AR, Paschero C, Gennarelli G, Silvagno F, Benedetto C, Revelli A.
Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization. Pharmaceuticals. 2020; 13(7):136.
https://doi.org/10.3390/ph13070136
Chicago/Turabian Style
Bergandi, Loredana, Stefano Canosa, Andrea Roberto Carosso, Carlotta Paschero, Gianluca Gennarelli, Francesca Silvagno, Chiara Benedetto, and Alberto Revelli.
2020. "Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization" Pharmaceuticals 13, no. 7: 136.
https://doi.org/10.3390/ph13070136
APA Style
Bergandi, L., Canosa, S., Carosso, A. R., Paschero, C., Gennarelli, G., Silvagno, F., Benedetto, C., & Revelli, A.
(2020). Human Recombinant FSH and Its Biosimilars: Clinical Efficacy, Safety, and Cost-Effectiveness in Controlled Ovarian Stimulation for In Vitro Fertilization. Pharmaceuticals, 13(7), 136.
https://doi.org/10.3390/ph13070136